Investigation of the binding of isoform-selective inhibitors to prostaglandin endoperoxide synthases using fluorescence spectroscopy

被引:28
作者
Lanzo, CA
Beechem, JM
Talley, J
Marnett, LJ
机构
[1] Vanderbilt Univ, Sch Med, Dept Biochem, AB Hancock Jt Mem Lab Canc Res, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Sch Med, Dept Chem, AB Hancock Jt Mem Lab Canc Res, Nashville, TN 37232 USA
[3] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA
[4] Searle Res & Dev, Dept Inflammatory Dis Res, St Louis, MO 63198 USA
关键词
D O I
10.1021/bi971691n
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Prostaglandin endoperoxide synthase (PGHS) is a heme protein that catalyzes the committed step in prostaglandin and thromboxane biosynthesis. Two isoforms of PGHS exist, a constitutive form termed PGHS-1 and an inducible form termed PGHS-2. We report here fluorescence resonance energy transfer analysis of isoform-selective inhibitors interacting with PGHS-1 and PGHS-2. By measuring fluorescence quenching due to the energy transfer of the inhibitor fluorescence to the heme prosthetic group of PGHS, we determined these inhibitors bind in the arachidonic acid substrate access channel with an R-0 of 35 Angstrom for PGHS-1 with the PGHS-1 inhibitor and an R-0 of 21 Angstrom for PGHS-2 with the PGHS-2 inhibitor. The observed fluorescence quenching is completely dynamic and dominated by quenching by the heme. Time-resolved results combined with molecular modeling determine the distance from the inhibitor to the heme moiety to be 20 Angstrom in PGHS-1 and 18 Angstrom in PGHS-2. Preliminary stopped-flow kinetic studies reveal that the rate of quenching is limited by a first-order protein transition, which is slow, and that bound inhibitor undergoes rapid exchange.
引用
收藏
页码:217 / 226
页数:10
相关论文
共 44 条
[21]   THE STRUCTURAL BASIS OF ASPIRIN ACTIVITY INFERRED FROM THE CRYSTAL-STRUCTURE OF INACTIVATED PROSTAGLANDIN H-2 SYNTHASE [J].
LOLL, PJ ;
PICOT, D ;
GARAVITO, RM .
NATURE STRUCTURAL BIOLOGY, 1995, 2 (08) :637-643
[22]   Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2 [J].
Luong, C ;
Miller, A ;
Barnett, J ;
Chow, J ;
Ramesha, C ;
Browner, MF .
NATURE STRUCTURAL BIOLOGY, 1996, 3 (11) :927-933
[23]   ARGININE-120 OF PROSTAGLANDIN G/H SYNTHASE-1 IS REQUIRED FOR THE INHIBITION BY NONSTEROIDAL ANTIINFLAMMATORY DRUGS CONTAINING A CARBOXYLIC-ACID MOIETY [J].
MANCINI, JA ;
RIENDEAU, D ;
FALGUEYRET, JP ;
VICKERS, PJ ;
ONEILL, GP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (49) :29372-29377
[24]  
MARNETT LJ, 1984, MOL PHARMACOL, V26, P328
[25]   SELECTIVE-INHIBITION OF INDUCIBLE CYCLOOXYGENASE-2 IN-VIVO IS ANTIINFLAMMATORY AND NONULCEROGENIC [J].
MASFERRER, JL ;
ZWEIFEL, BS ;
MANNING, PT ;
HAUSER, SD ;
LEAHY, KM ;
SMITH, WG ;
ISAKSON, PC ;
SEIBERT, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (08) :3228-3232
[26]  
MEADE EA, 1993, J BIOL CHEM, V268, P6610
[27]   SELECTIVITY OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS AS INHIBITORS OF CONSTITUTIVE AND INDUCIBLE CYCLOOXYGENASE [J].
MITCHELL, JA ;
AKARASEREENONT, P ;
THIEMERMANN, C ;
FLOWER, RJ ;
VANE, JR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (24) :11693-11697
[28]   ISOLATION AND PROPERTIES OF INTERMEDIATES IN PROSTAGLANDIN BIOSYNTHESIS [J].
NUGTEREN, DH ;
HAZELHOF, E .
BIOCHIMICA ET BIOPHYSICA ACTA, 1973, 326 (03) :448-461
[29]  
OBANION MK, 1991, J BIOL CHEM, V265, P16737
[30]  
ODENWALLER R, 1990, METHOD ENZYMOL, V187, P479